Hospitals Insurance Pharmaceutical Companies 
STAT
AUGUST 31, 2023
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
STAT
FEBRUARY 15, 2024
For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
AUGUST 9, 2024
In addition, individuals with diabetic kidney disease can take Invokana to reduce the risk of worsened kidney function, death, and hospitalization. The average cost of Invokana without insurance can range between $600 and $800 for a 30-day supply. Without insurance, the cost of Invokana can reach over $7,200 annually.
STAT
MARCH 13, 2024
In a setback to the pharmaceutical industry, a U.S. appeals court has upheld an Arkansas law that allows hospitals participating in a controversial federal discount program to ship medicines to certain pharmacies. There are roughly 12,400 hospitals and clinics that participate across the U.S.
STAT
JULY 19, 2023
The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly.
STAT
SEPTEMBER 30, 2024
The heads of pharmaceutical companies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls. Those figures compared to an average of $13 million and median of $4.3 million in 2022. Continue to STAT+ to read the full story…
Hospital Pharmacy Europe
FEBRUARY 6, 2025
Rising drug costs are putting increasing pressure on healthcare systems, highlighting the need for rational and responsible medicines use, according to a new study looking at cost-effective and sustainable drug use in hospitals. Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach. 2024 Dec 19.
Expert insights. Personalized for you.
144 
Let's personalize your content